Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma

R. J. Motzer, A. Rakhit, M. Ginsberg, K. Rittweger, J. Vuky, R. Yu, S. Fettner, L. Hooftman

Research output: Contribution to journal › Article › peer-review

90 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences